Artemis Medicare Services Ltd Gains 5.78%: 4 Key Factors Driving the Surge

17 minutes ago
share
Share Via
Artemis Medicare Services Ltd delivered a strong weekly performance, rising 5.78% from Rs.338.45 to Rs.358.00 between 21 and 25 September 2026, significantly outperforming the Sensex which declined 0.76% over the same period. The stock’s rally was marked by a notable intraday surge on 25 September, hitting new 52-week and all-time highs amid robust trading volumes and institutional interest, underscoring its resilience and momentum within the hospital sector.

Key Events This Week

21 Sep: Stock opens at Rs.338.10, marginal decline of 0.10%

22 Sep: Gains 0.95% to Rs.341.30 despite Sensex dip

23 Sep: Modest rise of 0.21% to Rs.342.00 with Sensex recovery

24 Sep: Sharp fall of 2.69% to Rs.332.80 amid broader market weakness

25 Sep: Strong rebound with 7.57% gain to Rs.358.00, hitting new highs

Week Open
Rs.338.45
Week Close
Rs.358.00
+5.78%
Week High
Rs.369.25
vs Sensex
-0.76%

21 September 2026: Quiet Start with Minor Decline

Artemis Medicare Services Ltd began the week at Rs.338.10, a slight dip of 0.10% from the previous close. The stock traded on moderate volume of 21,226 shares while the Sensex advanced 0.46%, closing at 35,787.64. This initial modest underperformance set a cautious tone ahead of the week’s developments.

22 September 2026: Recovery Amid Market Weakness

The stock rebounded by 0.95% to Rs.341.30 despite the Sensex retreating 0.32% to 35,672.04. Lower volume of 15,574 shares accompanied this gain, signalling selective buying interest. Artemis Medicare’s relative strength on a down day for the broader market hinted at underlying resilience.

23 September 2026: Modest Gains with Market Rally

On 23 September, Artemis Medicare edged up 0.21% to Rs.342.00 on subdued volume of 7,578 shares. The Sensex recovered strongly, gaining 0.56% to 35,870.78. The stock’s limited upside despite market strength suggested consolidation ahead of a more significant move.

24 September 2026: Sharp Pullback on Weak Market Sentiment

The stock corrected sharply, falling 2.69% to Rs.332.80 on increased volume of 12,870 shares. This decline coincided with a broad market sell-off as the Sensex dropped 1.62% to 35,291.38. The pullback reflected profit-taking and sector-wide pressure, temporarily halting the stock’s upward momentum.

From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!

  • - Early turnaround signals
  • - Explosive growth potential
  • - Textile - Machinery recovery play

Position for Explosive Growth →

25 September 2026: Breakout Rally to New Highs

Artemis Medicare Services Ltd staged a remarkable recovery on the final trading day, surging 7.57% to close at Rs.358.00 on massive volume of 1,251,893 shares. The stock hit an intraday 52-week high of Rs.369.25 and an all-time high near Rs.361.5, reflecting strong buying interest and technical strength. This rally outpaced the Sensex’s modest 0.18% gain, highlighting the stock’s leadership within the hospital sector.

The day’s performance was characterised by a 2.97% gap-up open and sustained momentum, with the stock trading comfortably above all key moving averages (5-day through 200-day). Intraday volatility was elevated at 13.42%, underscoring active price discovery and robust investor participation. Institutional interest was evident as Artemis Medicare emerged among the most actively traded stocks by value, with a traded value of ₹247.56 crores and a total volume of 67.81 lakh shares.

Technical indicators such as MACD and Bollinger Bands signalled bullish momentum on weekly and monthly charts, while delivery volumes showed mixed trends, suggesting some short-term caution despite the strong price action. The company’s Mojo Score of 78.0 and recent upgrade to a Buy rating by MarketsMOJO on 8 June 2026 further support the positive outlook.

Date Stock Price Day Change Sensex Day Change
2026-09-21 Rs.338.10 -0.10% 35,787.64 +0.46%
2026-09-22 Rs.341.30 +0.95% 35,672.04 -0.32%
2026-09-23 Rs.342.00 +0.21% 35,870.78 +0.56%
2026-09-24 Rs.332.80 -2.69% 35,291.38 -1.62%
2026-09-25 Rs.358.00 +7.57% 35,353.29 +0.18%

Key Takeaways

Strong Outperformance: Artemis Medicare Services Ltd outpaced the Sensex by over 6.5 percentage points during the week, driven by a powerful rally on 25 September that saw the stock hit new 52-week and all-time highs.

Robust Financial and Technical Profile: The company’s solid fundamentals, including a low Debt to EBITDA ratio of 1.39, consistent profit growth of 33.45% annually, and a healthy ROCE of 14.21%, underpin the stock’s strength. Technical indicators confirm sustained bullish momentum across multiple timeframes.

Institutional Interest and Liquidity: High trading volumes and significant traded value on 25 September highlight strong institutional participation, although a slight dip in delivery volumes suggests some short-term caution among longer-term investors.

Risks to Monitor: The elevated promoter share pledge of 44.53% remains a notable risk factor that could introduce volatility during market downturns. Investors should remain attentive to this aspect alongside broader sector and macroeconomic developments.

Curious about Artemis Medicare Services Ltd from ? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!

  • - Detailed research coverage
  • - Technical + fundamental view
  • - Decision-ready insights

Get the Complete Analysis →

Conclusion

Artemis Medicare Services Ltd’s performance in the week ending 25 September 2026 was marked by a decisive rebound and strong price appreciation, culminating in new 52-week and all-time highs. The stock’s ability to outperform the Sensex amid a mixed market environment reflects its robust financial health, positive technical signals, and growing institutional interest. While the high promoter pledge warrants caution, the company’s consistent earnings growth and favourable valuation metrics support its current momentum. Overall, Artemis Medicare remains a standout within the hospital sector, demonstrating resilience and potential for continued strength in the near term.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News